Schizophrenia, a neurodevelopmental illness;Les schizophrénies, maladies du neurodéveloppement

Annales Pharmaceutiques Francaises

Volumn 67, Issue 4, 2009, Pages 251-255

  Olie J P ^a,b,c   Mouaffak, F ^a,b,c   Krebs, M O ^a,b,c   Loo H ^a,b,c  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SHU   (France)

Author keywords

Development gene; Neurodevelopment; Schizophrenia; Vulnerability

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA PROTEIN 1; DYSBINDIN; GENE PRODUCT; NEU DIFFERENTIATION FACTOR; REELIN; UNCLASSIFIED DRUG;

COGNITIVE DEFECT; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIFESPAN; LOW BIRTH WEIGHT; MOTOR DEVELOPMENT; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROIMAGING; NEUROLOGIC DISEASE; ONSET AGE; PERINATAL PERIOD; PHENOTYPE; PRENATAL PERIOD; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCREENING TEST; SHORT SURVEY; SOCIAL LEARNING; STRUCTURAL CHROMOSOME ABERRATION; VULNERABLE POPULATION;

HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; SCHIZOPHRENIA;

EID: 67649945836     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2009.02.009     Document Type: Short Survey

References (37)

1. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56 (1999) 162-182
2. Singh S.M., McDonald P., Murphy B., and O'Reilly R. Incidental neurodevelopmental episodes in the etiology of schizophrenia: an expanded model involving epigenetics and development. Clin Genet 65 (2004) 435-440
3. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10 (2005) 434-449
4. Gourion D., Gourevitch R., Leprovost J.B., Olie J.P., and Krebs M.O. Neurodevelopmental hypothesis in schizophrenia. L'Encéphale 30 (2004) 109-118
5. Maynard T.M., Sikich L., Lieberman J.A., and LaMantia A.S. Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull 27 (2001) 457-476
6. Parnas J., Cannon T.D., Jacobsen B., Schulsinger H., Schulsinger F., and Mednick S.A. Lifetime DSM-III-R diagnostic outcomes in the offspring of schizophrenic mothers. Results from the Copenhagen High-Risk Study. Arch Gen Psychiatry 50 (1993) 707-714
7. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159 (2002) 1080-1092
8. Insel B.J., Schaefer C.A., McKeague I.W., Susser E.S., and Brown A.S. Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry 65 (2008) 1136-1144
9. Schiffman J., Walker E., Ekstrom M., Schulsinger F., Sorensen H., and Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry 161 (2004) 2021-2027
10. Walker E.F., Savoie T., and Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull 20 (1994) 441-451
11. Jones P., Rodgers B., Murray R., and Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344 (1994) 1398-1402
12. Done D.J., Crow T.J., Johnstone E.C., and Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 309 (1994) 699-703
13. Alaghband-Rad J., McKenna K., Gordon C.T., Albus K.E., Hamburger S.D., Rumsey J.M., et al. Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry 34 (1995) 1273-1283
14. Nicolson R., and Rapoport J.L. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry 46 (1999) 1418-1428
15. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., and Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 156 (1999) 1328-1335
16. Gochman P.A., Greenstein D., Sporn A., Gogtay N., Keller B., Shaw P., et al. IQ stabilization in childhood-onset schizophrenia. Schizophr Res 77 (2005) 271-277
17. Wilke M., Sohn J.H., Byars A.W., and Holland S.K. Bright spots: correlations of gray matter volume with IQ in a normal pediatric population. Neuroimage 20 (2003) 202-215
18. Kim-Cohen J., Caspi A., Moffitt T.E., Harrington H., Milne B.J., and Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 60 (2003) 709-717
19. Dazzan P., and Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl 43 (2002) s50-s57
20. Krebs M.O., Gut-Fayand A., Bourdel M., Dischamp J., and Olie J. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res 45 (2000) 245-260
21. Hirayasu Y., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156 (1999) 1091-1093
22. Frazier J.A., Giedd J.N., Hamburger S.D., Albus K.E., Kaysen D., Vaituzis A.C., et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 53 (1996) 617-624
23. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (2000) 16-25
24. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
25. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 11650-11655
26. Arnold S.E., Ruscheinsky D.D., and Han L.Y. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 42 (1997) 639-647
27. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney Jr. W.E., and Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53 (1996) 425-436
28. Arnold S.E., Talbot K., and Hahn C.G. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 147 (2005) 319-345
29. Schurov I.L., Handford E.J., Brandon N.J., and Whiting P.J. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol Psychiatry 9 (2004) 1100-1110
30. Mackie S., Millar J.K., and Porteous D.J. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 17 (2007) 95-102
31. Morris J.A., Kandpal G., Ma L., Austin C.P., and DISC1. (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 12 (2003) 1591-1608
32. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7 (2004) 575-580
33. Longart M., Liu Y., Karavanova I., and Buonanno A. Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 472 (2004) 156-172
34. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 (2008) 539-543
35. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008;455:237-41.
36. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008) 232-236
37. Jarskog L.F., Selinger E.S., Lieberman J.A., and Gilmore J.H. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl2 ratio without caspase-3 activation. Am J Psychiatry 161 (2004) 109-115